// App-Quantinova.ai

: Chimeric Antigen Receptor T Cells Specific for CLL-1 for Treatment of Acute Myeloid Leukemia

Researchers

Presenter

  • Elisa De Togni

Principal Investigators

  • Miriam Y Kim

  • Matt L Cooper

  • Julie Ritchey

  • Julie O'Neal

  • Jessica Niswonger

  • John F. DiPersio

Medical Centers

  • Washington University in St Louis, St. Louis, MO

  • Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO.

  • Division of Oncology, Washington University School of Medicine, St. Louis, MO

  • Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO.

  • Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO.

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Acute myelocytic leukemia

Biomarkers

  • Cluster of Differentiation 107 Antigen-Like Family Member A

  • Cluster of Differentiation 19

  • Cluster of Differentiation 2AP

  • Cluster of differentiation 8A

  • Coxsackie Virus And Adenovirus Receptor

  • Galectin-3

Drug/Treatment

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved